Early echocardiographic alterations in cancer patients during chemotherapy

Aim. To evaluate the early manifestation of cardiotoxicity after the first course of multiagent chemotherapy (MAC) using echocardiography with an assessment of the left ventricular ejection fraction (LVEF) and global longitudinal strain (GLS).Material and methods. The study included 49 cancer patien...

Full description

Bibliographic Details
Main Authors: Z. Z.A. Fashafsha, P. Sh. Chomakhidze, D. F. Mesitskaya, A. Yu. Suvorov, M. I. Sekacheva, E. V. Poddubskaya, E. S. Tyukanova, M. V. Sankova, M. A. Ozova, V. D. Levina, D. А. Andreev, F. Yu. Kopylov
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2022-12-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/5093
_version_ 1826560987487010816
author Z. Z.A. Fashafsha
P. Sh. Chomakhidze
D. F. Mesitskaya
A. Yu. Suvorov
M. I. Sekacheva
E. V. Poddubskaya
E. S. Tyukanova
M. V. Sankova
M. A. Ozova
V. D. Levina
D. А. Andreev
F. Yu. Kopylov
author_facet Z. Z.A. Fashafsha
P. Sh. Chomakhidze
D. F. Mesitskaya
A. Yu. Suvorov
M. I. Sekacheva
E. V. Poddubskaya
E. S. Tyukanova
M. V. Sankova
M. A. Ozova
V. D. Levina
D. А. Andreev
F. Yu. Kopylov
author_sort Z. Z.A. Fashafsha
collection DOAJ
description Aim. To evaluate the early manifestation of cardiotoxicity after the first course of multiagent chemotherapy (MAC) using echocardiography with an assessment of the left ventricular ejection fraction (LVEF) and global longitudinal strain (GLS).Material and methods. The study included 49 cancer patients with elective MAC.Results. After the first administration of a therapeutic dose of chemotherapy, a decrease in LVEF ≥10 and GLS >15 was demonstrated in more than 6,1% of patients, as well as a subclinical decrease in LVEF ≥5% in 22,4% and a decrease in GLS ≥12% in 24,5%.Conclusion. In cancer patients, after the first course of chemotherapy, GLS dynamics should be assessed during echocardiography as a marker of myocardial dysfunction.
first_indexed 2024-04-09T20:43:16Z
format Article
id doaj.art-569fb9aa9b164e0a8a9d656d51859cca
institution Directory Open Access Journal
issn 1560-4071
2618-7620
language Russian
last_indexed 2025-03-14T09:25:01Z
publishDate 2022-12-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj.art-569fb9aa9b164e0a8a9d656d51859cca2025-03-02T11:43:00Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202022-12-01271110.15829/1560-4071-2022-50933636Early echocardiographic alterations in cancer patients during chemotherapyZ. Z.A. Fashafsha0P. Sh. Chomakhidze1D. F. Mesitskaya2A. Yu. Suvorov3M. I. Sekacheva4E. V. Poddubskaya5E. S. Tyukanova6M. V. Sankova7M. A. Ozova8V. D. Levina9D. А. Andreev10F. Yu. Kopylov11I.M. Sechenov First Moscow State Medical UniversityI.M. Sechenov First Moscow State Medical UniversityI.M. Sechenov First Moscow State Medical UniversityI.M. Sechenov First Moscow State Medical UniversityI.M. Sechenov First Moscow State Medical UniversityI.M. Sechenov First Moscow State Medical UniversityI.M. Sechenov First Moscow State Medical UniversityI.M. Sechenov First Moscow State Medical UniversityI.M. Sechenov First Moscow State Medical UniversityI.M. Sechenov First Moscow State Medical UniversityI.M. Sechenov First Moscow State Medical UniversityI.M. Sechenov First Moscow State Medical UniversityAim. To evaluate the early manifestation of cardiotoxicity after the first course of multiagent chemotherapy (MAC) using echocardiography with an assessment of the left ventricular ejection fraction (LVEF) and global longitudinal strain (GLS).Material and methods. The study included 49 cancer patients with elective MAC.Results. After the first administration of a therapeutic dose of chemotherapy, a decrease in LVEF ≥10 and GLS >15 was demonstrated in more than 6,1% of patients, as well as a subclinical decrease in LVEF ≥5% in 22,4% and a decrease in GLS ≥12% in 24,5%.Conclusion. In cancer patients, after the first course of chemotherapy, GLS dynamics should be assessed during echocardiography as a marker of myocardial dysfunction.https://russjcardiol.elpub.ru/jour/article/view/5093cardiotoxicitymyocardial dysfunctionleft ventricular ejection fractionglobal longitudinal strain
spellingShingle Z. Z.A. Fashafsha
P. Sh. Chomakhidze
D. F. Mesitskaya
A. Yu. Suvorov
M. I. Sekacheva
E. V. Poddubskaya
E. S. Tyukanova
M. V. Sankova
M. A. Ozova
V. D. Levina
D. А. Andreev
F. Yu. Kopylov
Early echocardiographic alterations in cancer patients during chemotherapy
Российский кардиологический журнал
cardiotoxicity
myocardial dysfunction
left ventricular ejection fraction
global longitudinal strain
title Early echocardiographic alterations in cancer patients during chemotherapy
title_full Early echocardiographic alterations in cancer patients during chemotherapy
title_fullStr Early echocardiographic alterations in cancer patients during chemotherapy
title_full_unstemmed Early echocardiographic alterations in cancer patients during chemotherapy
title_short Early echocardiographic alterations in cancer patients during chemotherapy
title_sort early echocardiographic alterations in cancer patients during chemotherapy
topic cardiotoxicity
myocardial dysfunction
left ventricular ejection fraction
global longitudinal strain
url https://russjcardiol.elpub.ru/jour/article/view/5093
work_keys_str_mv AT zzafashafsha earlyechocardiographicalterationsincancerpatientsduringchemotherapy
AT pshchomakhidze earlyechocardiographicalterationsincancerpatientsduringchemotherapy
AT dfmesitskaya earlyechocardiographicalterationsincancerpatientsduringchemotherapy
AT ayusuvorov earlyechocardiographicalterationsincancerpatientsduringchemotherapy
AT misekacheva earlyechocardiographicalterationsincancerpatientsduringchemotherapy
AT evpoddubskaya earlyechocardiographicalterationsincancerpatientsduringchemotherapy
AT estyukanova earlyechocardiographicalterationsincancerpatientsduringchemotherapy
AT mvsankova earlyechocardiographicalterationsincancerpatientsduringchemotherapy
AT maozova earlyechocardiographicalterationsincancerpatientsduringchemotherapy
AT vdlevina earlyechocardiographicalterationsincancerpatientsduringchemotherapy
AT daandreev earlyechocardiographicalterationsincancerpatientsduringchemotherapy
AT fyukopylov earlyechocardiographicalterationsincancerpatientsduringchemotherapy